A new peptide may hold potential as an Alzheimer’s treatment

Boston MA (SPX) Apr 18, 2023

MIT neuroscientists have found a way to reverse neurodegeneration and other symptoms of Alzheimer’s disease by interfering with an enzyme that is typically overactive in the brains of Alzheimer’s patients.

When the researchers treated mice with a peptide that blocks the hyperactive version of an enzyme called CDK5, they found dramatic reductions in neurodegeneration and DNA damage in the b
http://dlvr.it/SmgbSX

Leave a comment